Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

25,720 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 7,363
Recruiting: 3,965
Ph III recruiting: 535
Growth YoY: +10.3%
Industry share: 25%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3,404)

clinicaltrialsPublishedShowing 451–500 of 521 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01924156	DC Vaccine Combined With CIK Cells in Patients With Renal Cell Carcinoma	unknown	Phase 1 / Phase 2	30	Affiliated Hospital to Academy of Military Medical SciencesOTHER	1	Feb 22, 2016	clinicaltrials
NCT01784107	A Phase Ib/II Trial of Belotecan and Ifosfamide in Patients With Extensive Disease of Small Cell Lung Cancer	unknown	Phase 1 / Phase 2	45	Gachon University Gil Medical CenterOTHER	1	Feb 10, 2016